5,117
Views
59
CrossRef citations to date
0
Altmetric
Reviews

The current status, challenges, and future developments of new tuberculosis vaccines

, &
Pages 1697-1716 | Received 28 Dec 2017, Accepted 25 Mar 2018, Published online: 14 May 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Subhashree Subhasmita Nayak, Guneswar Sethi & Krishna Ramadas. (2023) Design of multi-epitope based vaccine against Mycobacterium tuberculosis: a subtractive proteomics and reverse vaccinology based immunoinformatics approach. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-19.
Read now
Ruda Wei, Pengchuan Li, Yong Xue, Yinping Liu, Wenping Gong & Weiguo Zhao. (2022) Impact of Diabetes Mellitus on the Immunity of Tuberculosis Patients: A Retrospective, Cross-Sectional Study. Risk Management and Healthcare Policy 15, pages 611-627.
Read now
Wenping Gong, Ashok Aspatwar, Shuyong Wang, Seppo Parkkila & Xueqiong Wu. (2021) COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials. Expert Review of Vaccines 20:7, pages 857-880.
Read now
Juan Alberto Guevara Salazar, Jessica Rubí Morán Díaz, Enrique Ramírez Segura & José Guadalupe Trujillo Ferrara. (2021) What are the origins of growing microbial resistance? Both Lamarck and Darwin were right. Expert Review of Anti-infective Therapy 19:5, pages 563-569.
Read now
Zhenyu Pan, Jun Zhang, Qingting Bu, Hairong He, Ling Bai, Jin Yang, Qingqing Liu & Jun Lyu. (2020) The Gap Between Global Tuberculosis Incidence and the First Milestone of the WHO End Tuberculosis Strategy: An Analysis Based on the Global Burden of Disease 2017 Database. Infection and Drug Resistance 13, pages 1281-1286.
Read now
Kathrin U. Jansen & Annaliesa S. Anderson. (2018) The role of vaccines in fighting antimicrobial resistance (AMR). Human Vaccines & Immunotherapeutics 14:9, pages 2142-2149.
Read now

Articles from other publishers (53)

Ifeanyi Elibe Mba, Hyelnaya Cletus Sharndama, Zikora Kizito Glory Anyaegbunam, Chijioke Chinedu Anekpo, Ben Chibuzo Amadi, Daji Morumda, Yandev Doowuese, Uchechi Justina Ihezuo, Joseph Ukomadu Chukwukelu & Onyekachi Philomena Okeke. (2023) Vaccine development for bacterial pathogens: Advances, challenges and prospects. Tropical Medicine & International Health 28:4, pages 275-299.
Crossref
Fan Jiang, Tiehui Sun, Peng Cheng, Jie Wang & Wenping Gong. (2023) A Summary on Tuberculosis Vaccine Development—Where to Go?. Journal of Personalized Medicine 13:3, pages 408.
Crossref
Wenping Gong, Jianping Xie, Hao Li & Ashok Aspatwar. (2023) Editorial: Research advances of tuberculosis vaccine and its implication on COVID-19. Frontiers in Immunology 14.
Crossref
Cong Peng, Fengjie Tang, Jie Wang, Peng Cheng, Liang Wang & Wenping Gong. (2023) Immunoinformatic-Based Multi-Epitope Vaccine Design for Co-Infection of Mycobacterium tuberculosis and SARS-CoV-2. Journal of Personalized Medicine 13:1, pages 116.
Crossref
Jie Wang, Jie Mi, Yan Liang, Xueqiong Wu, Junxian Zhang, Yinping Liu, Lan Wang, Yong Xue, Yingchang Shi, Wenping Gong & Xinru Wang. (2023) RNA-seq Analysis of the BCG Vaccine in a Humanized Mouse Model. Zoonoses 3:1.
Crossref
Emma Whitlow, Abu Salim Mustafa & Shumaila Nida Muhammad Hanif. 2023. Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges. Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges 211 232 .
Ziwei Wu, Ziyi Chen, Siyu Long, Aiping Wu & Hongsheng Wang. (2022) Incidence of pulmonary tuberculosis under the regular COVID-19 epidemic prevention and control in China. BMC Infectious Diseases 22:1.
Crossref
Xiaochun Wang, Jianpeng Du, Yanpeng Zhang, Tao Zhu, Lirong Mao, Lifa Xu, Zilun Shi, Jingyan Zhang, Qishan Sun, Zhiyang Qi & Lu Xia. (2022) Construction and expression of Mycobacterium tuberculosis fusion protein AR2 and its immunogenicity in combination with various adjuvants to form vaccine. Tuberculosis 137, pages 102270.
Crossref
Liang Chen, Jie Hua & Xiaopu He. (2022) Coexpression Network Analysis-Based Identification of Critical Genes Differentiating between Latent and Active Tuberculosis. Disease Markers 2022, pages 1-11.
Crossref
Cong Peng, Zongwei Guo, Yue Zhao, Rui Li, Liang Wang & Wenping Gong. (2022) Effect of Lymphocyte Subsets on Bone Density in Senile Osteoporosis: A Retrospective Study. Journal of Immunology Research 2022, pages 1-11.
Crossref
Wenping Gong, Yan Liang, Jie Mi, Yong Xue, Jie Wang, Lan Wang, Yusen Zhou, Shihui Sun & Xueqiong Wu. (2022) A peptide-based vaccine ACP derived from antigens of Mycobacterium tuberculosis induced Th1 response but failed to enhance the protective efficacy of BCG in mice. Indian Journal of Tuberculosis 69:4, pages 482-495.
Crossref
Shaik Faazil, M. Shaheer Malik, Saleh A. Ahmed, Reem I. Alsantali, Poornachandra Yedla, Meshari A. Alsharif, Iqbal N. Shaikh & Ahmed Kamal. (2022) Novel linezolid-based oxazolidinones as potent anticandidiasis and antitubercular agents. Bioorganic Chemistry 126, pages 105869.
Crossref
Monalisa Martins Trentini, Alex Issamu Kanno, Dunia Rodriguez, Lazaro Moreira Marques-Neto, Silas Fernandes Eto, Ana Marisa Chudzinki-Tavassi & Luciana Cezar de Cerqueira Leite. (2022) Recombinant BCG expressing the LTAK63 adjuvant improves a short-term chemotherapy schedule in the control of tuberculosis in mice. Frontiers in Immunology 13.
Crossref
Wenping Gong, Yan Liang, Jie Wang, Yinping Liu, Yong Xue, Jie Mi, Pengchuan Li, Xiaoou Wang, Lan Wang & Xueqiong Wu. (2022) Prediction of Th1 and Cytotoxic T Lymphocyte Epitopes of Mycobacterium tuberculosis and Evaluation of Their Potential in the Diagnosis of Tuberculosis in a Mouse Model and in Humans . Microbiology Spectrum 10:4.
Crossref
Yinyin Zhu, Rong Wang, Mengkai Qiao, Minghe Guo, Yan Kong & Hongying Zhang. (2022) WITHDRAWN: Analysis of the application value of molecular diagnostic technology of mycobacterium tuberculosis. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, pages 100330.
Crossref
Saman Soleimanpour, Atieh Yaghoubi, Fereshteh Sadat Seddighinia & S.A. Rahim Rezaee. (2022) A century of attempts to develop an effective tuberculosis vaccine: Why they failed?. International Immunopharmacology 109, pages 108791.
Crossref
Dmitry A. Kudlai & N. P. Doktorova. (2022) ESAT-6 and CFP-10 antigens as a biotechnology molecule substrate. Applications in medicine. Russian Journal of Infection and Immunity 12:3, pages 439-449.
Crossref
Rasul Hoseinpur, Alka Hasani, Behzad Baradaran, Jalal Abdolalizadeh, Yousef Amini, Roya Salehi, Hossein Samadi Kafil, Khalil Azizian, Mohammad Yousef Memar, Pourya Gholizadeh & Akbar Hasani. (2022) Chitosan nanoparticles containing fusion protein (Hspx–PPE44–EsxV) and resiquimod adjuvant (HPERC) as a novel booster vaccine for Mycobacterium tuberculosis . Journal of Biomaterials Applications 37:1, pages 40-47.
Crossref
Peng Cheng, Liang Wang & Wenping Gong. (2022) In silico Analysis of Peptide-Based Biomarkers for the Diagnosis and Prevention of Latent Tuberculosis Infection. Frontiers in Microbiology 13.
Crossref
Zaixing Jia, Wenping Gong, Yan Liang, Xueqiong Wu & Weiguo Zhao. (2021) Prediction and analyses of HLA‐II restricted Mycobacterium tuberculosis CD4 + T cell epitopes in the Chinese population . Biotechnology and Applied Biochemistry 69:3, pages 1002-1014.
Crossref
Milena Maya-Hoyos, Dulce Mata-Espinosa, Manuel O. López-Torres, Blanca Tovar-Vázquez, Jorge Barrios-Payán, Juan C. León-Contreras, Marisol Ocampo, Rogelio Hernández-Pando & Carlos Y. Soto. (2022) The ctpF Gene Encoding a Calcium P-Type ATPase of the Plasma Membrane Contributes to Full Virulence of Mycobacterium tuberculosis. International Journal of Molecular Sciences 23:11, pages 6015.
Crossref
Cara M. Gill, Lorraine Dolan, Laura M. Piggott & Anne Marie McLaughlin. (2022) New developments in tuberculosis diagnosis and treatment. Breathe 18:1, pages 210149.
Crossref
Soumik Barman, Dheeraj Soni, Byron Brook, Etsuro Nanishi & David J. Dowling. (2022) Precision Vaccine Development: Cues From Natural Immunity. Frontiers in Immunology 12.
Crossref
Wenping Gong, Chao Pan, Peng Cheng, Jie Wang, Guangyu Zhao & Xueqiong Wu. (2022) Peptide-Based Vaccines for Tuberculosis. Frontiers in Immunology 13.
Crossref
Hussain A. Safar, Abu Salim Mustafa, Hanady A. Amoudy & Ahmed El-Hashim. (2022) The Effect of Delivery Systems on the Induction of T Helper 1 Cell Response to an ESAT6-Like Protein Rv3619c and Identification of Its Immunodominant Peptides. Medical Principles and Practice 31:4, pages 359-367.
Crossref
Shobana Sundar, Lokesh Thangamani & Shanmughavel Piramanayagam. (2021) Computational identification of significant immunogenic epitopes of the putative outer membrane proteins from Mycobacterium tuberculosis. Journal of Genetic Engineering and Biotechnology 19:1.
Crossref
Jie Mi, Yan Liang, Jianqin Liang, Wenping Gong, Shuyong Wang, Junxian Zhang, Zhiming Li & Xueqiong Wu. (2021) The Research Progress in Immunotherapy of Tuberculosis. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Wenping Gong & Xueqiong Wu. (2021) Differential Diagnosis of Latent Tuberculosis Infection and Active Tuberculosis: A Key to a Successful Tuberculosis Control Strategy. Frontiers in Microbiology 12.
Crossref
Sean Saramago, Joana Magalhães & Marina Pinheiro. (2021) Tuberculosis Vaccines: An Update of Recent and Ongoing Clinical Trials. Applied Sciences 11:19, pages 9250.
Crossref
Anke Osterloh. (2021) Vaccine Design and Vaccination Strategies against Rickettsiae. Vaccines 9:8, pages 896.
Crossref
Rongchuan Zhao, Tao Luo, Pengjiao Ma, Liang Ge, Zonghai Chen, Xinyan Wang, Wei Liao & Lang Bao. (2021) Improvement of the immunogenicity of ESAT-6 via fusion with the dodecameric protein dodecin of Mycobacterium tuberculosis. Microbial Pathogenesis 155, pages 104890.
Crossref
Nicole M Paterson, Hussein Al-Zubieri & Matthew F Barber. (2021) Diversification of CD1 Molecules Shapes Lipid Antigen Selectivity. Molecular Biology and Evolution 38:6, pages 2273-2284.
Crossref
Aregitu Mekuriaw Arega, Kali Prasad Pattanaik, Sasmita Nayak & Rajani Kanta Mahapatra. (2021) Computational discovery and ex-vivo validation study of novel antigenic vaccine candidates against tuberculosis. Acta Tropica 217, pages 105870.
Crossref
Wenping Gong, Yan Liang, Jie Mi, Zaixing Jia, Yong Xue, Jie Wang, Lan Wang, Yusen Zhou, Shihui Sun & Xueqiong Wu. (2021) Peptides-Based Vaccine MP3RT Induced Protective Immunity Against Mycobacterium Tuberculosis Infection in a Humanized Mouse Model. Frontiers in Immunology 12.
Crossref
Guangbo Wu & Qiang Fan. (2020) Pancreatic tuberculosis: a clinical diagnostic challenge. ANZ Journal of Surgery 91:4, pages 747-749.
Crossref
Farheen Fatma, Dinesh K. Tripathi, Mrigank Srivastava, Kishore K. Srivastava & Ashish Arora. (2021) Immunological characterization of chimeras of high specificity antigens from Mycobacterium tuberculosis H37Rv. Tuberculosis 127, pages 102054.
Crossref
Jianwei Jiang, Yuke Liu, Xiao Liu, Dongfeng Zhang, Haihong Huang, Baolian Wang, Li Sheng & Yan Li. (2021) Simultaneous determination of a novel oxazolidinone anti-tuberculosis OTB-658 and its metabolites in monkey blood by LC-MS/MS. Journal of Chromatography B 1167, pages 122552.
Crossref
Eliza Kramarska, Flavia Squeglia, Flavio De Maio, Giovanni Delogu & Rita Berisio. (2021) PE_PGRS33, an Important Virulence Factor of Mycobacterium tuberculosis and Potential Target of Host Humoral Immune Response. Cells 10:1, pages 161.
Crossref
Wen-Ping Gong, Yan Liang, Yan-Bo Ling, Jun-Xian Zhang, You-Rong Yang, Lan Wang, Jie Wang, Ying-Chang Shi & Xue-Qiong Wu. (2020) Effects of Mycobacterium vaccae vaccine in a mouse model of tuberculosis: protective action and differentially expressed genes. Military Medical Research 7:1.
Crossref
Franck J. D. Mennechet & Guy R. Takoudjou Dzomo. (2020) Coping with COVID-19 in Sub-Saharan Africa: What Might the Future Hold?. Virologica Sinica 35:6, pages 875-884.
Crossref
Kelsey M. Loupy, Thomas Lee, Cristian A. Zambrano, Ahmed I. Elsayed, Heather M. D’Angelo, Laura K. Fonken, Matthew G. Frank, Steven F. Maier & Christopher A. Lowry. (2020) Alzheimer’s Disease: Protective Effects of Mycobacterium vaccae, a Soil-Derived Mycobacterium with Anti-Inflammatory and Anti-Tubercular Properties, on the Proteomic Profiles of Plasma and Cerebrospinal Fluid in Rats. Journal of Alzheimer's Disease 78:3, pages 965-987.
Crossref
E. Whitlow, A. S. Mustafa & S. N. M. Hanif. (2020) An Overview of the Development of New Vaccines for Tuberculosis. Vaccines 8:4, pages 586.
Crossref
Zhihao Li, Changping Zheng, Marco Terreni, Lisa Tanzi, Matthieu Sollogoub & Yongmin Zhang. (2020) Novel Vaccine Candidates against Tuberculosis. Current Medicinal Chemistry 27:31, pages 5095-5118.
Crossref
Meili Wei, Yongjie Zhao, Zhuoyu Qian, Biao Yang, Jun Xi, Jun Wei & Bikui Tang. (2020) Pneumonia caused by Mycobacterium tuberculosis. Microbes and Infection 22:6-7, pages 278-284.
Crossref
Pornpen Tantivitayakul, Wuthiwat Ruangchai, Tada Juthayothin, Nat Smittipat, Areeya Disratthakit, Surakameth Mahasirimongkol, Wasna Viratyosin, Katsushi Tokunaga & Prasit Palittapongarnpim. (2020) Homoplastic single nucleotide polymorphisms contributed to phenotypic diversity in Mycobacterium tuberculosis. Scientific Reports 10:1.
Crossref
Abul K. Azad, Christopher Lloyd, Wolfgang Sadee & Larry S. Schlesinger. (2020) Challenges of Immune Response Diversity in the Human Population Concerning New Tuberculosis Diagnostics, Therapies, and Vaccines. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Huifeng Yang, Yang Zhan, Haotian Wu & Liangbi Xiang. (2020) Bacillus Calmette-Guérin (BCG) stimulates changes in dendritic cell surface marker expression in vitamin D-deficient mice. Journal of International Medical Research 48:3, pages 030006051989689.
Crossref
Wenping Gong, Yan Liang & Xueqiong Wu. (2020) Animal Models of Tuberculosis Vaccine Research: An Important Component in the Fight against Tuberculosis. BioMed Research International 2020, pages 1-21.
Crossref
兰 杨. (2020) Research Progress on Molecular Mechanism of Drug Resistance of Mycobacterium tuberculosis. Advances in Clinical Medicine 10:07, pages 1292-1297.
Crossref
Chunhua Wang, Jinbiao Lu, Weixin Du, Guozhi Wang, Xuguang Li, Xiaobin Shen, Cheng Su, Lei Yang, Baowen Chen, Junzhi Wang & Miao Xu. (2019) Ag85b/ESAT6-CFP10 adjuvanted with aluminum/poly-IC effectively protects guinea pigs from latent mycobacterium tuberculosis infection. Vaccine 37:32, pages 4477-4484.
Crossref
Kerry‐Ann F. O'Grady, Allan W. Cripps & Keith Grimwood. (2018) Paediatric and adult bronchiectasis: Vaccination in prevention and management. Respirology 24:2, pages 107-114.
Crossref
Yinyin Zhu, Jianming Wang, Mengkai Qiao, Minghe Guo, Yan Kong & Hongying Zhang. (2022) Analysis of the Application Value of Molecular Diagnostic Technology of Mycobacterium Tuberculosis. SSRN Electronic Journal.
Crossref
Yan Kong, Chen Yang, Yinyin Zhu, Jun Zhu, Dehua Kong & Hongying Zhang. (2022) Analysis on the Application Value of Molecular Diagnostic Technology of Mycobacterium Tuberculosis. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.